AAVantgarde Bio
Entity

  • AAVantgarde Bio

  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    2,720

  • Activities

    biotech deeptech healthtech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Milan, Metropolitan City of Milan, Italy

    Milan

    Italy

  • Employees

    Scale: 11-50

    Estimated: 38

  • Engaged corporates

    1
    1 0

  • Added in Motherbase

    1 year, 5 months ago
Description
  • Value proposition

    Delivering the next generation gene therapies

    AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors

    Gene Therapy, Ophthalmology, and Rare diseases

Corporate interactions BETA
Corporate TypeTweets Articles
Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services 		Other

12 Nov 2024


Similar entities
Last news
Show all articles
Social network dynamics